Ortiz wants audit of stem-cell institute
By Sacramento Business Journal,
Sacramento Business Journal
| 02. 22. 2006
State Sen. Deborah Ortiz and 10 other California legislators have asked for an audit of the California Institute for Regenerative Medicine.
CIRM, which oversees stem-cell research money in the state, was created by Proposition 71, which voters approved in 2004.
Ortiz, a Sacramento Democrat, wrote SB 18, a stem-cell oversight bill vetoed by Gov. Arnold Schwarzenegger, with Sen. George Runner, a Republican from Lancaster. In his veto message, Schwarzenegger called the bill's proposed changes to the law that created the stem-cell institute illegal, and urged legislators to pursue an audit through the Joint Legislative Audit Committee.
Ortiz's letter to the audit committee asks for an audit by Sept. 30, 2006 of CIRM and the Independent Citizens' Oversight Committee that governs it.
Ortiz and the others intended to present their request to the committee on Wednesday in Sacramento, but the hearing was postponed, possibly until March 8, according to Ortiz's office.
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...